Combat Disorders: Clinical Trials

10 trials for Combat Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 not yet recruiting. 10 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 210Not yet recruiting 10

Follow Combat Disorders: new trials by email Literature Review of Combat Disorders trials Research Report on Combat Disorders

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Written Exposure Therapy Plus Adjunctive Methylphenidate Treatment for Veterans With PTSD
Written Exposure Therapy (WET), methylphenidate (MPH), placebo (PBO) - PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingVA Office of Research and Development1382027-07-012026-10-29
Inhaled Cannabis for Treatment of PTSD
High THC Cannabis, Placebo cannabis - Post Traumatic Stress Disorder PTSD
Phase 2Not yet recruitingMultidisciplinary Association for Psychedelic Studies3202027-02-012026-08-11
Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
Transcranial Magnetic Stimulation, Psilocybin (drug), Neurofeedback - PTSD, PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingUniversity of New Mexico1502026-12-312026-10-30
ONE-P TMS Military Veterans
D-Cycloserine (DCS), Placebo, Intermittent Theta Burst Stimulation (iTBS) - PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingFidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA502026-11-012026-08-20
ONE-P TMS First Responders
D-Cycloserine (DCS), Placebo, Intermittent Theta Burst Stimulation (iTBS) - PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingFidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA502026-11-012026-08-19
Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder
TREATMENT ARM: Full dose, CONTROL ARM: Active-controlled - PTSD, Post Traumatic Stress Disorder PTSD
Phase 2Not yet recruitingU.S. Army Medical Research and Development Command862026-10-012026-07-15
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
Psilocybin - Post Traumatic Stress Disorder PTSD, Intimate Partner Violence (IPV)
Phase 2Not yet recruitingUniversity of Calgary762026-10-012026-09-08
Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence
Propranolol, 120mg, Placebo - PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingUniversity Hospital, Tours342026-09-012026-03-05
Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans
PT150, Placebo - PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingSan Diego Veterans Healthcare System1202026-04-012025-12-23
Ketamine Treatment for PTSD and MDD in TBI
IV ketamine, Midazolam - PTSD, Post Traumatic Stress Disorder, Major Depressive Disorder
Phase 2Not yet recruitingMinneapolis Veterans Affairs Medical Center402024-03-012024-01-29

Narrower conditions

Stress Disorders, Post-Traumatic (7)  ·  Depressive Disorder, Major (2)  ·  Wounds and Injuries (2)  ·  Brain Injuries, Traumatic (1)  ·  Depression (1)  ·  Marijuana Abuse (1)  ·  Mental Disorders (1)  ·  Suicidal Ideation (1)

Broader conditions

Stress Disorders, Traumatic (10)  ·  Trauma and Stressor Related Disorders (10)  ·  Mental Disorders (9)  ·  Behavior (2)  ·  Behavioral Symptoms (2)  ·  Depressive Disorder (2)  ·  Mood Disorders (2)  ·  Brain Diseases (1)  ·  Brain Injuries (1)  ·  Central Nervous System Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Craniocerebral Trauma (1)  ·  Nervous System Diseases (1)  ·  Self-Injurious Behavior (1)  ·  Substance-Related Disorders (1)

Interventions

Cycloserine (2)  ·  Psilocybin (2)  ·  (11R,13S,17S)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta(a)phenanthren-3-one (1)  ·  Ketamine (1)  ·  Methylphenidate (1)  ·  Midazolam (1)  ·  Neurofeedback (1)  ·  Pharmaceutical Preparations (1)  ·  Propranolol (1)  ·  Transcranial Magnetic Stimulation (1)

Sponsors

Fidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA (2)  ·  Minneapolis Veterans Affairs Medical Center (1)  ·  Multidisciplinary Association for Psychedelic Studies (1)  ·  San Diego Veterans Healthcare System (1)  ·  U.S. Army Medical Research and Development Command (1)  ·  University Hospital, Tours (1)  ·  University of Calgary (1)  ·  University of New Mexico (1)  ·  VA Office of Research and Development (1)

Countries

Canada (3)  ·  United States (3)

Top investigators

Fidel Vila-Rodriguez, M.D., PhD, FRCPC, DFAPA (2)  ·  Andrea Townsend, PhD (1)  ·  Davin Quinn, MD (1)  ·  Leah Mayo, PhD (1)  ·  Pamela Kryskow, MD, CCFP (1)  ·  Paul van Donkelaar, PhD (1)  ·  Sandy Shultz, PhD (1)  ·  Shannon Ford, MD (1)  ·  Victoria B Risbrough (1)  ·  Victoria Risbrough, PhD (1)  ·  Zachary Walsh, PhD (1)

NIH funding

2023 (1)